- Received FDA approval for ZEVASKYN™ (prademagene zamikeracel), the first and only autologous cell-based gene therapy for the treatment of…
New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals SYDNEY,…
Bringing Clarity and Confidence to Ultrasound-Guided Interventional Procedures SANTA CLARA, Calif., Aug. 13, 2025 /PRNewswire/ -- DeepSight Technology, a medical…
AI-powered delivery date prediction model shows high accuracy and improved performance over time, with promise for global maternal health impact…
Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory ApprovalReceives $5.3 Million Installment…
156% 3-Year Growth, as AI-Driven Pulse Platform Scales in Home-Based Care RCM CHARLOTTE, N.C., Aug. 13, 2025 /PRNewswire/ -- Prochant,…
NIAGARA FALLS, N.Y., Aug. 13, 2025 /PRNewswire/ -- Bizmatics, the maker of PrognoCIS EHR, is a leading provider of Electronic…
YARDLEY, Pa., Aug. 13, 2025 /PRNewswire/ -- 314e Corporation, a leader in healthcare IT software and solutions, announced its flagship product,…
IRVING, Texas, Aug. 13, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision…
Program Designed to Increase Use of Recommended Medication Therapy by Connecting with Providers in Workflow LOUISVILLE, Ky. and ARLINGTON, Va.,…